Clevidipine
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433913This classification denotes a calcium channel blocker with the molecular formula C21H23Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19O2GP3B7Q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but generally known as clevidipine, which bears US NIH Compound Identifier 153994. European Medicines Agency schedules Clevidipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06655MIG. The term CLEVIDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules clevidipine in its Anatomical Therapeutic Chemical (ATC) Classification. CLEVIDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clevidipine under HS 29333999 and SITC 51574. As of Q4 2014, CLEVIDIPINE remains the US FDA Preferred Term for this commodity. Clevidipine bears US NLM identifiers UMLS ID C0766108 and NCI Concept Code C72727. SMILES: Clc1c(C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)OCOC(=O)CCC)cccc1Cl.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.